JPRN-jRCT1080221649未知4 期
Clinical evaluation of 1.5% Levofloxacin ophthalmic solution in ophthalmic preoperative sterilization
适应症
试验速览
- 阶段
- 4 期
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •20 years or older at the time of acquisition of the informed consent
- •- those who are scheduled for cataract surgery
排除标准
- •- those with a history of serious adverse reaction including hypersensitivity to fluoroquinolone
- •- those judged by the investigator to be otherwise inappropriate as subjects
研究者
相似试验
已完成
4 期
Ocular Tissue Levels of 1.5% Levofloxacin Ophthalmic Solution Compared to an Active ComparatorCataractNCT00630019Santen Inc.96
Unknown
1 期
The Clinical Safety of Levofloxacin 1.5% vs Topical Moxifloxacin 0.5%Endophthalmitis PostoperativeNCT04212429National University of Malaysia128
Unknown
1 期
The Pharmacokinetics of Topical Levofloxacin 1.5% vs Topical Moxifloxacin 0.5%EndophthalmitisNCT04214821National University of Malaysia128
已完成
不适用
Efficacy and Safety of treatment with Levofloxacin for Community-acquired PneumoniaCommunity-acquired pneumonia in adultsJPRN-UMIN000008677Second Division, Department of Internal Medicine, Hamamatsu university school of medicine300
尚未招募
2 期
evofloxacin in treatment of tuberculosis infection of brain in childreCTRI/2024/07/070282All India Institute of Medical Sciences, Rishikesh